Last update:

Gastroenterology news

New approach opens rare immune cells to genetic risk research

Much of how genetic risk leads to disease has remained hidden. In many cases, genetic variants linked to disease do not act on nearby genes along the chromosome. Instead, they influence genes located far away along the DNA ...

A new target in the gut for reducing Alzheimer's risk

A compound produced by bacteria in many people's digestive tracts increases the risk of developing Alzheimer's disease and speeds cognitive decline in dementia patients, making it a potential target for a treatment that could ...

Patients with IBD face elevated risk of psychiatric disorders

Patients with inflammatory bowel disease (IBD) face a significantly higher risk of psychiatric disorders starting two to three years before diagnosis and lasting up to a decade afterward, according to a nationwide study published ...

Virtual tumor predicts response to liver cancer immunotherapy

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular ...

Q&A: Rise in cyclosporiasis cases

Cyclosporiasis is a gastrointestinal illness caused by the microscopic parasite Cyclospora. People contract cyclosporiasis by consuming food or water contaminated with feces containing Cyclospora parasites. Health officials ...

KRAS-targeting drugs show promise for rare appendix cancer

Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.